Cost-Utility Analysis of Angiotensin Receptor–Neprilysin Inhibitor Sacubitril/Valsartan Compared with Ace Inhibitors for the Treatment of Chronic Heart Failure in the United States
May 1, 2016, 00:00
10.1016/j.jval.2016.03.120
https://www.valueinhealthjournal.com/article/S1098-3015(16)00188-1/fulltext
Title :
Cost-Utility Analysis of Angiotensin Receptor–Neprilysin Inhibitor Sacubitril/Valsartan Compared with Ace Inhibitors for the Treatment of Chronic Heart Failure in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00188-1&doi=10.1016/j.jval.2016.03.120
First page :
A49
Section Title :
Cardiovascular Disorders - Cost Studies
Open access? :
No
Section Order :
1456